CEO Stock Ownership, Recall Timing, and Stock Market Penalties

Jessica L. Darby, D. Ketchen, George P. Ball, U. Mukherjee
{"title":"CEO Stock Ownership, Recall Timing, and Stock Market Penalties","authors":"Jessica L. Darby, D. Ketchen, George P. Ball, U. Mukherjee","doi":"10.1287/msom.2021.0175","DOIUrl":null,"url":null,"abstract":"Problem definition: Firms often delay the decision to recall faulty medical devices long after they become aware of a defect, thereby putting public safety at heightened risk. However, the factors contributing to these delays are not well-understood. To help address this gap, we examine whether and how CEO stock ownership influences the speed with which faulty medical devices are recalled and whether this influence varies with recall severity. We then examine whether the stock market penalizes firms differently based on recall decision-making speed and whether this penalty also varies with recall severity. Methodology/results: We collect data on 2,144 medical device recalls across 50 public medical device firms from 2002 to 2015. We use accelerated failure time models to test the effects of CEO stock ownership on the time-to-recall and event study methodology to examine how the time-to-recall influences stock market returns. Supplementary analyses shed further light on underlying mechanisms. Robustness checks demonstrate consistent results, including coarsened exact matching, reverse causality tests, Cox proportional hazard models, generalized linear regression models, and a mediation analysis. Firms whose CEOs possess greater ownership stakes recall medical devices more slowly, and this recall-slowing effect is accentuated for high-severity recalls. Delaying recalls magnifies the stock market penalty attributable to the recall, particularly for high-severity recalls. Managerial implications: Our study highlights an ownership characteristic of firms that are more likely to delay recalling faulty medical devices. Boards of directors can use insights from our study as they oversee product-quality decisions and determine the level and form of CEO compensation, and the FDA can use our findings to identify firms that might warrant extra scrutiny and better allocate its limited monitoring resources. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2021.0175 .","PeriodicalId":119284,"journal":{"name":"Manufacturing & Service Operations Management","volume":"81 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Manufacturing & Service Operations Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1287/msom.2021.0175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Problem definition: Firms often delay the decision to recall faulty medical devices long after they become aware of a defect, thereby putting public safety at heightened risk. However, the factors contributing to these delays are not well-understood. To help address this gap, we examine whether and how CEO stock ownership influences the speed with which faulty medical devices are recalled and whether this influence varies with recall severity. We then examine whether the stock market penalizes firms differently based on recall decision-making speed and whether this penalty also varies with recall severity. Methodology/results: We collect data on 2,144 medical device recalls across 50 public medical device firms from 2002 to 2015. We use accelerated failure time models to test the effects of CEO stock ownership on the time-to-recall and event study methodology to examine how the time-to-recall influences stock market returns. Supplementary analyses shed further light on underlying mechanisms. Robustness checks demonstrate consistent results, including coarsened exact matching, reverse causality tests, Cox proportional hazard models, generalized linear regression models, and a mediation analysis. Firms whose CEOs possess greater ownership stakes recall medical devices more slowly, and this recall-slowing effect is accentuated for high-severity recalls. Delaying recalls magnifies the stock market penalty attributable to the recall, particularly for high-severity recalls. Managerial implications: Our study highlights an ownership characteristic of firms that are more likely to delay recalling faulty medical devices. Boards of directors can use insights from our study as they oversee product-quality decisions and determine the level and form of CEO compensation, and the FDA can use our findings to identify firms that might warrant extra scrutiny and better allocate its limited monitoring resources. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2021.0175 .
CEO持股、召回时机和股票市场处罚
问题定义:企业往往在意识到缺陷很久之后才决定召回有缺陷的医疗设备,从而使公共安全面临更大的风险。然而,造成这些延误的因素还没有得到很好的理解。为了帮助解决这一差距,我们研究了CEO持股是否以及如何影响缺陷医疗设备召回的速度,以及这种影响是否随着召回的严重程度而变化。然后,我们研究了股票市场是否会根据召回决策速度对公司进行不同的惩罚,以及这种惩罚是否也会随着召回的严重程度而变化。方法/结果:我们收集了2002年至2015年50家公共医疗器械公司2144次医疗器械召回的数据。我们使用加速失效时间模型来检验CEO持股对召回时间的影响,并使用事件研究方法来检验召回时间对股票市场收益的影响。补充分析进一步阐明了潜在的机制。稳健性检验显示出一致的结果,包括粗化精确匹配、反向因果关系检验、Cox比例风险模型、广义线性回归模型和中介分析。首席执行官拥有更多股权的公司召回医疗设备的速度更慢,这种召回减缓效应在严重召回中更为突出。推迟召回会放大召回造成的股市损失,尤其是对于严重程度较高的召回。管理启示:我们的研究突出了公司的所有权特征,这些公司更有可能推迟召回有缺陷的医疗设备。董事会在监督产品质量决策、决定CEO薪酬的水平和形式时,可以利用我们的研究得出的见解,FDA可以利用我们的发现来识别可能需要额外审查的公司,并更好地分配其有限的监控资源。补充材料:在线附录可在https://doi.org/10.1287/msom.2021.0175上获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信